Artal Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Artal Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-110,532	Closed	-$721K	–	48
2024 Q2	$721K	Hold	110,532	–	–	0.02%	96
2024 Q1	$963K	Hold	110,532	–	–	0.02%	94
2023 Q4	$1.26M	Hold	110,532	–	–	0.04%	70
2023 Q3	$1.06M	Hold	110,532	–	–	0.05%	76
2023 Q2	$1.18M	Hold	110,532	–	–	0.04%	88
2023 Q1	$1.16M	Hold	110,532	–	–	0.07%	91
2022 Q4	$1.37M	Hold	110,532	–	–	0.08%	99
2022 Q3	$1.15M	Hold	110,532	–	–	0.05%	109
2022 Q2	$1.27M	Hold	110,532	–	–	0.07%	114
2022 Q1	$1.39M	Hold	110,532	–	–	0.06%	118
2021 Q4	$1.29M	Hold	110,532	–	–	0.04%	136
2021 Q3	$1.44M	Hold	110,532	–	–	0.03%	139
2021 Q2	$1.42M	Hold	110,532	–	–	0.03%	139
2021 Q1	$1.24M	Hold	110,532	–	–	0.02%	140
2020 Q4	$1.26M	Hold	110,532	–	–	0.03%	126
2020 Q3	$994K	Hold	110,532	–	–	0.02%	130
2020 Q2	$1.14M	Hold	110,532	–	–	0.03%	130
2020 Q1	$1.11M	Hold	110,532	–	–	0.05%	100
2019 Q4	$1.47M	Hold	110,532	–	–	0.06%	95
2019 Q3	$949K	Hold	110,532	–	–	0.04%	101
2019 Q2	$1.21M	Sell	110,532 -21,443	-16%	-$240K	0.05%	99
2019 Q1	$1.25M	Hold	131,975	–	–	0.05%	101
2018 Q4	$1.15M	Hold	131,975	–	–	0.04%	100
2018 Q3	$2.04M	Sell	131,975 -126,979	-49%	-$2.01M	0.05%	99
2018 Q2	$4.15M	Hold	258,954	–	–	0.09%	73
2018 Q1	$3.35M	Sell	258,954 -358,200	-58%	-$4.46M	0.04%	85
2017 Q4	$7.75M	Sell	617,154 -358,200	-37%	-$4.68M	0.12%	54
2017 Q3	$12.9M	Buy	975,354 +238,800	+32%	+$3.29M	0.22%	33
2017 Q2	$11.6M	Sell	736,554 -119,400	-14%	-$1.73M	0.2%	33
2017 Q1	$12.2M	Buy	855,954 +238,800	+39%	+$3.26M	0.27%	33
2016 Q4	$7.9M	Buy	617,154 +358,200	+138%	+$4.52M	0.18%	42
2016 Q3	$3.44M	Hold	258,954	–	–	0.07%	72
2016 Q2	$2.84M	Hold	258,954	–	–	0.06%	55
2016 Q1	$2.37M	Hold	258,954	–	–	0.05%	50
2015 Q4	$2.51M	Hold	258,954	–	–	0.05%	72
2015 Q3	$2.26M	Hold	258,954	–	–	0.05%	67
2015 Q2	$2.62M	Hold	258,954	–	–	0.11%	62
2015 Q1	$3.47M	Hold	258,954	–	–	0.16%	63
2014 Q4	$3.32M	Hold	258,954	–	–	0.12%	74
2014 Q3	$2.81M	Hold	258,954	–	–	0.1%	78
2014 Q2	$3.33M	Hold	258,954	–	–	0.13%	74
2014 Q1	$2.67M	Hold	258,954	–	–	0.1%	85
2013 Q4	$2.52M	Hold	258,954	–	–	0.09%	77
2013 Q3	$2.57M	Hold	258,954	–	–	0.08%	70
2013 Q2	$2.15M	Buy	+258,954	New	+$3.14M	0.07%	83

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group's IRWD Position: Q3 2024 in Review

Artal Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 110,532 shares — an estimated $721K sold.

Artal Group first reported a position in IRWD in Q2 2013 and held it in 45 quarters. The position peaked at $12.9M in Q3 2017. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

Artal Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Artal Group sold 110,532 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $721K.
Artal Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 45 quarters.
Artal Group's Ironwood Pharmaceuticals position peaked at $12.9M in Q3 2017.
221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.